{"id":"W2030638302","doi":"10.1200/jco.2014.56.5853","title":"Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American Society of Hematology","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Clinical endpoint; Oncology; Clinical trial; Surgery; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002759075,0.001147407,0.001468132,0.0004178747,0.0004980056,0.0006743904,0.001156531,0.001925258,0.01964438],"category_scores_gemma":[0.002228464,0.0004232583,0.001143192,0.0003731416,0.0005235264,0.0008413225,0.000506991,0.00191073,0.002484828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008898328,"about_ca_system_score_gemma":0.001577873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007257281,"about_ca_topic_score_gemma":0.001926189,"domain_scores_codex":[0.9986161,0.0009667612,0.00006141074,0.0001088035,0.0001048157,0.0001421625],"domain_scores_gemma":[0.9991639,0.0001613412,0.0002332656,0.00008739562,0.00009396806,0.0002602313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.926342,0.006860276,0.00142293,0.001915693,0.0007852124,0.0001195647,0.00006060722,0.0007433274,0.003053688,0.0006454422,0.01328278,0.04476856],"study_design_scores_gemma":[0.969487,0.02216469,0.00211879,0.0000674661,0.0001312667,0.00004366507,0.00000661585,0.0003999208,0.0001932316,0.0002046831,0.00517437,0.000008345053],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7216076,0.01484853,0.004167853,0.00476263,0.001743623,0.1886242,0.02490972,0.0007732041,0.03856261],"genre_scores_gemma":[0.7353482,0.00433193,0.008978096,0.007932241,0.0008538992,0.1893803,0.01823809,0.0001019342,0.03483531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01964438,"threshold_uncertainty_score":0.06571698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1323763385589371,"score_gpt":0.4866372121782168,"score_spread":0.3542608736192796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}